High-dose chemotherapy with autologous stem cell transplantation in extranodal NK/T-cell lymphoma: a retrospective comparison with non-transplantation cases.
Kim, H J; Bang, S M; Lee, J; Kwon, H C; Suh, C; Kim, H J; Lee, J H; Ryoo, B Y; Park, Y H; Kwon, J M; Oh, S Y; Lee, H R; Kim, K; Jung, C W; Park, K; Kim, W S.
Bone Marrow Transplant
; 37(9): 819-24, 2006 May.
Artigo em Inglês | MEDLINE | ID: mdl-16547486
The survival outcome of patients with relapsed/refractory peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma.
Comparison of survival in patients with T cell lymphoma after autologous and allogeneic stem cell transplantation as a frontline strategy or in relapsed disease.
Hematopoietic stem cell transplantation in nodal T cell non-hodgkin lymphomas: revisiting the issues.
Vorinostat Combined with High-Dose Gemcitabine, Busulfan, and Melphalan with Autologous Stem Cell Transplantation in Patients with Refractory Lymphomas.
Dismal outcome of T-cell lymphoma patients failing first-line treatment: results of a population-based study from the Modena Cancer Registry.
[Clinicopathological analysis of patients with angioimmunoblastic T-cell lymphoma (AILT)].
Treatment response in enteropathy associated T-cell lymphoma; survival in a large multicenter cohort.
Lymphoma-associated hemophagocytic lymphohistiocytosis: experience in adults from a single institution.
[Long-term results of treatment for T-cell lymphoblastic lymphomas].
The Clinical Utility of Circulating Epstein-Barr Virus DNA Concentrations in NK/T-Cell Lymphoma: A Meta-Analysis.